Mean SUVmax and SUVmean in Metastatic Lesions Before and After Sandostatin LAR Treatment
| Metastatic foci | No. of assessed lesions | Type of SUV | SUV before treatment (mean ± SD) | SUV after treatment (mean ± SD) | P |
| Liver | 73 | SUVmax | 20.7 ± 7.6 | 23.3 ± 9.3 | 0.153 |
| SUVmean | 16.5 ± 5.7 | 17.5 ± 6.2 | 0.473 | ||
| Lymph node | 60 | SUVmax | 18.3 ± 11.1 | 19.7 ± 16.1 | 0.876 |
| SUVmean | 13.8 ± 9.0 | 14.2 ± 7.6 | 0.755 | ||
| Bone | 23 | SUVmax | 26.0 ± 13.1 | 26.9 ± 10.7 | 0.571 |
| SUVmean | 20.8 ± 12.0 | 21.2 ± 10.5 | 0.798 | ||
| Lung | 2 | SUVmax | 10.3 ± 2.25 | 12.3 ± 5.35 | 0.776 |
| SUVmean | 7.5 ± 2.3 | 9.2 ± 3.8 | 0.759 |